Tag Archives: ALXN

Top 5 Warren Buffett Stocks To Own For 2019

Aniruddha Meher

“If past history was all there was to the game, the richest people would be librarians.”

– Warren Buffett

Investing, particularly investing well, is not the easiest game in the world. It requires a multitude of virtues like patience, keeping faith in your investment and the important ability to admit it when a mistake has been made. Even the doyen of investing Warren Buffett admitted he made a mistake about his Berkshire stock saying

“I’ve made lots of dumb decisions. That’s part of the game.”

There are a few basics that are vital to hold on to while investing. So much so, we believe it would be nearly impossible to be successful in the field without these four building blocks of investment.

related news Market Crash: 5 essentials while reviewing your equity and mutual fund portfolio Budget 2018: LTCG and DDT; is there need to restructure your portfolio?

1. Set the right goals

Top 5 Warren Buffett Stocks To Own For 2019: US Ecology, Inc.(ECOL)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on US Ecology (ECOL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Shares of US Ecology Inc (NASDAQ:ECOL) have been assigned an average rating of “Hold” from the seven brokerages that are currently covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1 year price target among brokerages that have covered the stock in the last year is $70.80.

  • [By Ethan Ryder]

    US Ecology Inc (NASDAQ:ECOL) Director Daniel Fox sold 900 shares of the firm’s stock in a transaction on Friday, August 24th. The stock was sold at an average price of $72.15, for a total value of $64,935.00. Following the transaction, the director now owns 5,140 shares in the company, valued at $370,851. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

  • [By Logan Wallace]

    BidaskClub upgraded shares of US Ecology (NASDAQ:ECOL) from a hold rating to a buy rating in a research note released on Thursday.

    Other equities research analysts have also recently issued reports about the stock. ValuEngine upgraded shares of US Ecology from a hold rating to a buy rating in a research report on Thursday, April 12th. Zacks Investment Research cut shares of US Ecology from a strong-buy rating to a hold rating in a research report on Tuesday, April 10th. Finally, UBS Group started coverage on shares of US Ecology in a research report on Wednesday, March 14th. They issued a sell rating and a $55.00 price target on the stock. One analyst has rated the stock with a sell rating, three have issued a hold rating and three have assigned a buy rating to the company. The stock currently has a consensus rating of Hold and an average target price of $58.80.

  • [By Motley Fool Transcribers]

    US Ecology Inc  (NASDAQ:ECOL)Q4 2018 Earnings Conference CallFeb. 22, 2019, 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 5 Warren Buffett Stocks To Own For 2019: CRB Futures Index(CR)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Crew Energy Inc (TSE:CR) – Cormark issued their Q1 2020 EPS estimates for shares of Crew Energy in a research note issued on Tuesday, March 5th. Cormark analyst A. Arif expects that the company will earn $0.06 per share for the quarter. Cormark also issued estimates for Crew Energy’s Q2 2020 earnings at $0.02 EPS, Q3 2020 earnings at $0.02 EPS and Q4 2020 earnings at $0.03 EPS.

  • [By Shane Hupp]

    BlackRock Inc. grew its stake in Crane Co. (NYSE:CR) by 2.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,303,084 shares of the conglomerate’s stock after acquiring an additional 93,264 shares during the period. BlackRock Inc. owned 7.21% of Crane worth $399,069,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    Crew Energy (TSE:CR) had its price objective lowered by equities research analysts at Canaccord Genuity from C$4.50 to C$4.00 in a report issued on Tuesday. Canaccord Genuity’s price objective indicates a potential upside of 101.01% from the stock’s previous close.

Top 5 Warren Buffett Stocks To Own For 2019: Alexion Pharmaceuticals, Inc.(ALXN)

Advisors’ Opinion:

  • [By Keith Speights]

    Three biotech stocks that have profited tremendously from their virtual monopolies are Alexion Pharmaceuticals (NASDAQ:ALXN), BioMarin Pharmaceutical (NASDAQ:BMRN), and Vertex Pharmaceuticals (NASDAQ:VRTX). Do these biotechs’ market positions make them winners for investors over the long run?

  • [By ]

    Alexion Pharmaceuticals Inc. (ALXN) is a U.S. pharma stock best known for its development of rare blood disorder drug Soliris. So far this drug has proved extremely successful. And now, the company is looking to expand into further treatment opportunities. The company is on the verge of snapping up Sweden’s Wilson Therapeutics for $855 million, further boosting (and diversifying) its rare disease lineup.

  • [By Shane Hupp]

    Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) gapped up before the market opened on Tuesday after Stifel Nicolaus raised their price target on the stock from $130.00 to $136.00. The stock had previously closed at $127.35, but opened at $128.69. Stifel Nicolaus currently has a hold rating on the stock. Alexion Pharmaceuticals shares last traded at $128.94, with a volume of 50491 shares.

  • [By Ethan Ryder]

    WARNING: “AGF Investments Inc. Takes $443,000 Position in Alexion Pharmaceuticals, Inc. (ALXN)” was reported by Ticker Report and is the property of of Ticker Report. If you are accessing this piece on another website, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be read at www.tickerreport.com/banking-finance/4188611/agf-investments-inc-takes-443000-position-in-alexion-pharmaceuticals-inc-alxn.html.

  • [By Chris Lange]

    Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) is breaking out from a bullish continuation pattern after completing a 2-year+ consolidation bottom. Upside is seen to the $200 area. Celgene Corp. (NASDAQ: CELG), Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), and Incyte Corp. (NASDAQ: INCY) have weaker technical patterns and may have further downside risks. BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is forming a potential bearish top – a move below $77.98 would open $71 to the $60 area.

  • [By Shane Hupp]

    These are some of the headlines that may have effected Accern’s scoring:

    Get Alexion Pharmaceuticals alerts:

    Q2 2018 EPS Estimates for Alexion Pharmaceuticals, Inc. Boosted by Analyst (ALXN) (americanbankingnews.com) What to Expect from Alexion Pharmaceuticals’ Q2 2018 Earnings (finance.yahoo.com) Why Most Analysts Recommend a ‘Buy’ for Alexion Stock (finance.yahoo.com) Alexion Pharmaceuticals’ Diversification Strategy Makes It A Solid Buy For 2018 (seekingalpha.com) Alexion Pharmaceuticals (ALXN) Scheduled to Post Quarterly Earnings on Wednesday (americanbankingnews.com)

    ALXN opened at $135.16 on Friday. The stock has a market cap of $30.06 billion, a P/E ratio of 26.19, a price-to-earnings-growth ratio of 1.21 and a beta of 1.08. Alexion Pharmaceuticals has a fifty-two week low of $102.10 and a fifty-two week high of $149.34. The company has a current ratio of 3.35, a quick ratio of 2.86 and a debt-to-equity ratio of 0.33.

Top 5 Warren Buffett Stocks To Own For 2019: MutualFirst Financial Inc.(MFSF)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on MutualFirst Financial (MFSF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on MutualFirst Financial (MFSF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    MutualFirst Financial, Inc. (NASDAQ:MFSF) – Stock analysts at DA Davidson increased their Q3 2018 earnings per share (EPS) estimates for shares of MutualFirst Financial in a research report issued to clients and investors on Monday, July 30th. DA Davidson analyst K. Reevey now forecasts that the bank will earn $0.68 per share for the quarter, up from their previous forecast of $0.62. DA Davidson has a “Neutral” rating on the stock. DA Davidson also issued estimates for MutualFirst Financial’s Q4 2018 earnings at $0.69 EPS, FY2018 earnings at $2.55 EPS and FY2019 earnings at $2.79 EPS.

  • [By Ethan Ryder]

    Media coverage about MutualFirst Financial (NASDAQ:MFSF) has trended somewhat negative recently, Accern Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. MutualFirst Financial earned a news impact score of -0.01 on Accern’s scale. Accern also assigned news articles about the bank an impact score of 47.9474560000459 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Top 5 Warren Buffett Stocks To Own For 2019: Ultragenyx Pharmaceutical Inc.(RARE)

Advisors’ Opinion:

  • [By Shane Hupp]

    Ultragenyx Pharmaceutical (NASDAQ:RARE) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Ultragenyx launched its second drug, Crysvita, in the United States to treat X-linked hypophosphatemia (XLH) in April. We are optimistic on the drug’s uptake. The drug was also approved in the EU in February on a conditional basis. In May, the company announced positive phase II data from the drug in pediatric setting, but according to the FDA those were not sufficient to support an NDA. Thus, the company is in discussions with FDA and EMA, which would provide further clarity regarding whether an additional study would be required for the approval. The company also remains focused on its two-gene therapy programs — DTX301 for ornithine transcarbamylase deficiency and DTX401 for glycogen storage disease type Ia. However, developmental or regulatory setbacks could result in higher operating expenses and the need for additional capital. Loss estimates have narrowed ahead of  Q3 earnings release.”

  • [By Motley Fool Transcribers]

    Ultragenyx Pharmaceutical Inc  (NASDAQ:RARE)Q4 2018 Earnings Conference CallFeb. 19, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Ultragenyx Pharmaceutical (RARE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Chris Lange]

    Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) is expected to report Phase 2 data from all its tumor-induced osteomalacia patients. Shares of Ultragenyx closed Friday at $76.87, in a 52-week range of $41.67 to $86.10 and with a consensus analyst target of $68.74.

  • [By Joseph Griffin]

    BidaskClub upgraded shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) from a hold rating to a buy rating in a report released on Monday.

    A number of other brokerages have also recently weighed in on RARE. JPMorgan Chase restated an overweight rating and issued a $66.00 price objective (down from $68.00) on shares of Ultragenyx Pharmaceutical in a research note on Wednesday, February 21st. Evercore ISI upgraded shares of Ultragenyx Pharmaceutical from an in-line rating to an outperform rating in a research note on Monday, January 22nd. Stifel Nicolaus restated a buy rating and issued a $74.00 price objective (down from $85.00) on shares of Ultragenyx Pharmaceutical in a research note on Wednesday, February 21st. ValuEngine upgraded shares of Ultragenyx Pharmaceutical from a sell rating to a hold rating in a research note on Wednesday, April 4th. Finally, Wedbush reiterated a positive rating and set a $71.00 target price (up from $64.00) on shares of Ultragenyx Pharmaceutical in a research note on Wednesday, April 18th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company. Ultragenyx Pharmaceutical presently has a consensus rating of Buy and an average price target of $69.76.

Top 10 Value Stocks To Buy For 2019

Los Angeles Capital Management & Equity Research Inc. reduced its position in shares of Aaron’s, Inc. (NYSE:AAN) by 17.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 44,145 shares of the company’s stock after selling 9,300 shares during the period. Los Angeles Capital Management & Equity Research Inc. owned 0.06% of Aaron’s worth $1,918,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Amalgamated Bank lifted its position in shares of Aaron’s by 13.5% during the second quarter. Amalgamated Bank now owns 10,222 shares of the company’s stock valued at $444,000 after purchasing an additional 1,218 shares in the last quarter. LPL Financial LLC lifted its position in shares of Aaron’s by 8.1% during the first quarter. LPL Financial LLC now owns 16,479 shares of the company’s stock valued at $768,000 after purchasing an additional 1,238 shares in the last quarter. Affinity Investment Advisors LLC lifted its position in shares of Aaron’s by 21.3% during the first quarter. Affinity Investment Advisors LLC now owns 8,318 shares of the company’s stock valued at $388,000 after purchasing an additional 1,459 shares in the last quarter. Great West Life Assurance Co. Can lifted its position in shares of Aaron’s by 5.1% during the first quarter. Great West Life Assurance Co. Can now owns 37,559 shares of the company’s stock valued at $1,751,000 after purchasing an additional 1,814 shares in the last quarter. Finally, Signaturefd LLC bought a new position in shares of Aaron’s during the first quarter valued at about $103,000.

Top 10 Value Stocks To Buy For 2019: National Commerce Corporation(NCOM)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on National Commerce (NCOM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    National Commerce (NASDAQ:NCOM) was downgraded by equities researchers at BidaskClub from a “strong-buy” rating to a “buy” rating in a research note issued on Saturday.

  • [By Logan Wallace]

    National Commerce (NASDAQ:NCOM) was downgraded by BidaskClub from a “strong-buy” rating to a “buy” rating in a research report issued on Friday.

  • [By Max Byerly]

    ValuEngine downgraded shares of National Commerce (NASDAQ:NCOM) from a hold rating to a sell rating in a research report released on Thursday.

    NCOM has been the subject of several other reports. BidaskClub upgraded shares of National Commerce from a buy rating to a strong-buy rating in a research report on Thursday, May 31st. Zacks Investment Research upgraded shares of National Commerce from a hold rating to a buy rating and set a $53.00 target price for the company in a research report on Wednesday, June 27th. Finally, Stephens reiterated a hold rating and set a $48.00 target price on shares of National Commerce in a research report on Thursday, July 26th. Two investment analysts have rated the stock with a sell rating and three have given a hold rating to the stock. The company currently has a consensus rating of Hold and an average target price of $48.67.

Top 10 Value Stocks To Buy For 2019: Stewart Information Services Corporation(STC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    StarChain (CURRENCY:STC) traded 8.7% lower against the US dollar during the 24-hour period ending at 20:00 PM E.T. on May 14th. StarChain has a market cap of $0.00 and approximately $5.27 million worth of StarChain was traded on exchanges in the last 24 hours. One StarChain token can now be purchased for about $0.0925 or 0.00001062 BTC on major cryptocurrency exchanges. During the last seven days, StarChain has traded down 16.3% against the US dollar.

  • [By Stephan Byrd]

    StarChain (CURRENCY:STC) traded down 2.8% against the dollar during the one day period ending at 21:00 PM Eastern on May 31st. One StarChain token can now be bought for about $0.0729 or 0.00000971 BTC on exchanges. StarChain has a market cap of $0.00 and approximately $2.12 million worth of StarChain was traded on exchanges in the last day. In the last seven days, StarChain has traded down 18.5% against the dollar.

  • [By Stephan Byrd]

    Argo Group (NASDAQ: AGII) and Stewart Information Services (NYSE:STC) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, profitability and analyst recommendations.

  • [By Logan Wallace]

    StarChain (CURRENCY:STC) traded 13% higher against the U.S. dollar during the one day period ending at 22:00 PM E.T. on June 3rd. StarChain has a total market capitalization of $0.00 and approximately $3.20 million worth of StarChain was traded on exchanges in the last day. One StarChain token can currently be purchased for about $0.0814 or 0.00001057 BTC on major cryptocurrency exchanges. In the last seven days, StarChain has traded 1.2% lower against the U.S. dollar.

  • [By Joseph Griffin]

    Bailard Inc. reduced its stake in shares of Stewart Information Services Corp (NYSE:STC) by 14.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,100 shares of the insurance provider’s stock after selling 1,400 shares during the period. Bailard Inc.’s holdings in Stewart Information Services were worth $335,000 as of its most recent SEC filing.

  • [By Max Byerly]

    Sangoma Technologies (CVE:STC) has been assigned a C$2.00 price objective by investment analysts at Acumen Capital in a research report issued to clients and investors on Tuesday. The brokerage currently has a “buy” rating on the stock. Acumen Capital’s target price suggests a potential upside of 70.94% from the stock’s current price.

Top 10 Value Stocks To Buy For 2019: Buckle, Inc. (BKE)

Advisors’ Opinion:

  • [By Logan Wallace]

    Buckle (NYSE:BKE) was downgraded by equities researchers at ValuEngine from a “buy” rating to a “hold” rating in a report released on Tuesday.

  • [By Taylor Cox]

    Notable Earnings

    Foot Locker, Inc (NYSE: FL) Q1 premarket
    The Buckle, Inc (NYSE: BKE) Q1 premarket

    FDA/Biotech

    BioMarin Pharmaceutical Inc (NASDAQ: BMRN) PDUFA date for Pegvaliase

    IPOs

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Zoe's Kitchen, Inc. (NYSE: ZOES) fell 27.8 percent to $10.45 in pre-market trading after the company reported weaker-than-expected earnings for its first quarter. The company also lowered its FY18 sales outlook from $358million-$368 million to $345 million-$352 million.
    Hibbett Sports, Inc. (NASDAQ: HIBB) shares fell 15.6 percent to $24.50 in pre-market trading after the company reported weaker-than-expected results for its first quarter.
    Rockwell Medical, Inc. (NASDAQ: RMTI) fell 15.5 percent to $5.02 in the pre-market trading session after the company disclosed that its President and CEO Robert Chioini was terminated.
    BG Staffing Inc (NYSE: BGSF) shares fell 12.7 percent to $19.00 in pre-market trading after reporting a common stock offering.
    8×8, Inc. (NASDAQ: EGHT) fell 9.3 percent to $20.00 in pre-market trading after reporting downbeat quarterly earnings.
    Asia Pacific Wire & Cable Corporation Limited (NASDAQ: APWC) fell 7.7 percent to $2.35 in pre-market trading after rising 3.88 percent on Thursday.
    Gap, Inc. (NYSE: GPS) shares fell 7.5 percent to $30.49 in pre-market trading after the company posted downbeat earnings for its first quarter on Thursday. Comps were up 1 percent in the quarter.
    California Resources Corporation (NYSE: CRC) fell 6.4 percent to $33.91 in pre-market trading.
    Buckle Inc (NYSE: BKE) fell 4.9 percent to $24.50 in pre-market trading following weak quarterly sales.
    China Rapid Finance Limited (NYSE: XRF) shares fell 4.9 percent to $3.13 in pre-market trading after climbing 11.53 percent on Thursday.
    Ross Stores, Inc. (NASDAQ: ROST) fell 4.8 percent to $78.98 in pre-market trading. Ross Stores reported upbeat earnings for its first quarter, but issued weak forecast for the current quarter.
    Callon Petroleum Company (NYSE: CPE) shares fell 4.7 percent to $11.90 in pre-market trading after the company reported pricing of common

  • [By Logan Wallace]

    6 Meridian bought a new stake in shares of Buckle Inc (NYSE:BKE) in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 8,243 shares of the company’s stock, valued at approximately $222,000.

  • [By Logan Wallace]

    Buckle (NYSE:BKE) was upgraded by investment analysts at ValuEngine from a “sell” rating to a “hold” rating in a research note issued on Tuesday.

Top 10 Value Stocks To Buy For 2019: Diebold, Incorporated(DBD)

Advisors’ Opinion:

  • [By Paul Ausick]

    Diebold Nixdorf Inc. (NYSE: DBD) dropped about 25% Friday to set a new 52-week low of $3.55. Shares closed at $4.75 on Thursday, and the stock’s 52-week high is $23.50. Volume totaled around 13 million, about six times the daily average. The company had no specific news.

  • [By Paul Ausick]

    Diebold Nixdorf Inc. (NYSE: DBD) fell by about 5.1% Friday to post a new 52-week low of $11.43 after closing at $12.05 on Thursday. The 52-week high is $28.80. Volume of about 4.4 million was about three times the daily average of about 1.4 million. The company had no specific news.

  • [By Matthew Frankel, CFP®]

    It’s been a rough couple of weeks for Diebold Nixdorf (NYSE:DBD) shareholders. After a disappointing earnings report that included the company saying it may have trouble with its debt load, and a subsequent wave of short-selling, Diebold plunged by a staggering 65% during the first nine days of August.

  • [By Shane Hupp]

    Diebold Nixdorf (NYSE:DBD) was downgraded by equities research analysts at ValuEngine from a “sell” rating to a “strong sell” rating in a report released on Tuesday.

  • [By Max Byerly]

    ILLEGAL ACTIVITY NOTICE: “Diebold Nixdorf (DBD) Bonds Rise 1.3% During Trading” was first posted by Ticker Report and is owned by of Ticker Report. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at www.tickerreport.com/banking-finance/4155454/diebold-nixdorf-dbd-bonds-rise-1-3-during-trading.html.

Top 10 Value Stocks To Buy For 2019: NEW GOLD INC.(NGD)

Advisors’ Opinion:

  • [By Ethan Ryder]

    New Gold (NYSEAMERICAN:NGD) had its price objective lowered by analysts at Royal Bank of Canada from $1.25 to $1.00 in a research report issued on Wednesday. The brokerage currently has an “underperform” rating on the basic materials company’s stock. Royal Bank of Canada’s target price indicates a potential upside of 14.50% from the stock’s current price.

  • [By Maxx Chatsko]

    Shares of New Gold (NYSEMKT:NGD) fell by over 14% today after the company announced the surprise sale of its Mesquite gold mine. The business will receive $158 million in cash for the productive asset, which management says will “immediately crystallize several years’ worth of future free cash flow as part of our strategy to prudently manage our balance sheet, providing the company with the financial flexibility to focus on our core assets”.

  • [By Paul Ausick]

    New Gold Inc. (NYSEAMERICAN: NGD) dropped about 2.9% Monday to post a new 52-week low of $2.35. Shares closed at $2.42 on Friday and the stock’s 52-week high is $4.25. Volume was about 10% below the daily average of around 5.8 million shares. The gold mining company had no news.

Top 10 Value Stocks To Buy For 2019: Mammoth Energy Services, Inc. (TUSK)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Axovant Sciences Ltd. (NASDAQ: AXON) shares rose 23.7 percent to $1.49. Axovant announced strengthening of management team and completion of organization restructuring which "enhanced capabilities in research and business development" and reduced internal headcount by 43 percent.
    Mammoth Energy Services, Inc. (NASDAQ: TUSK) shares jumped 19.8 percent to $37.3148. Mammoth Energy’s subsidiary Cobra signed a new $900 million contract to finish the restoration of critical electrical services and support the initial phase of reconstruction of the electrical utility system in Puerto Rico.
    Acorn International, Inc. (NYSE: ATV) shares gained 19 percent to $34.0201. Acorn shares rose Friday after the company declared a special one-time cash dividend of $14.97 per ADS.
    DHI Group, Inc. (NYSE: DHX) shares surged 19 percent to $2.20.
    My Size, Inc. (NASDAQ: MYSZ) climbed 16.8 percent to $1.18 after the company received a Notice of Allowance from the USPTO for measurement technology patent.
    Global Eagle Entertainment Inc. (NASDAQ: ENT) gained 16.6 percent to $2.32.
    Leju Holdings Limited (NYSE: LEJU) gained 16.5 percent to $1.34 following Q1 beat.
    Evolus, Inc. (NASDAQ: EOLS) shares surged 16.5 percent to $26.1499. Evolus named Lauren Silvernail as Chief Financial Officer and Executive Vice President, Corporate Development.
    Jupai Holdings Limited (NYSE: JP) shares gained 15 percent to $26.29 after reporting Q1 results.
    Momo Inc. (NASDAQ: MOMO) shares gained 15 percent to $44.7702 after the company reported better-than-expected results for its first quarter and issued strong sales forecast for the second quarter.
    Windstream Holdings, Inc. (NASDAQ: WIN) rose 15 percent to $7.075.
    China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) gained 14.4 percent to $2.746.
    American Woodmark Corporation (NASDAQ: AMWD) climbed 14.2 percent to $101.10 after the company reported upbeat Q4 results.
    Savara Inc. (NAS
  • [By Shane Hupp]

    Mammoth Energy Services Inc (NASDAQ:TUSK) – Analysts at Jefferies Financial Group upped their Q2 2018 earnings per share (EPS) estimates for shares of Mammoth Energy Services in a research report issued to clients and investors on Tuesday, July 10th. Jefferies Financial Group analyst E. Royes now expects that the energy company will post earnings per share of $1.62 for the quarter, up from their previous forecast of $1.40. Jefferies Financial Group currently has a “Hold” rating and a $30.00 price target on the stock. Jefferies Financial Group also issued estimates for Mammoth Energy Services’ Q4 2018 earnings at $1.58 EPS, FY2018 earnings at $6.15 EPS, FY2019 earnings at $4.85 EPS and FY2020 earnings at $4.60 EPS.

  • [By Shane Hupp]

    Mammoth Energy Services (NASDAQ:TUSK) and National Energy Services (NASDAQ:NESR) are both small-cap oils/energy companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership and earnings.

  • [By Shane Hupp]

    Shares of Mammoth Energy Services (NASDAQ:TUSK) hit a new 52-week high and low on Wednesday . The stock traded as low as $35.94 and last traded at $34.62, with a volume of 20978 shares trading hands. The stock had previously closed at $34.58.

  • [By Ethan Ryder]

    Mammoth Energy Services (NASDAQ: TUSK) and North American Construction Group (NYSE:NOA) are both small-cap oils/energy companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, earnings and dividends.

Top 10 Value Stocks To Buy For 2019: German American Bancorp, Inc.(GABC)

Advisors’ Opinion:

  • [By Logan Wallace]

    German American Bancorp, Inc. (NASDAQ:GABC) – Research analysts at FIG Partners increased their FY2018 earnings estimates for German American Bancorp in a research report issued to clients and investors on Wednesday, May 2nd. FIG Partners analyst B. Martin now anticipates that the bank will post earnings of $2.02 per share for the year, up from their prior estimate of $2.00.

Top 10 Value Stocks To Buy For 2019: TC PipeLines, LP(TCP)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on TC Pipelines (TCP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Goldman Sachs Group initiated coverage on shares of TC Pipelines (NYSE:TCP) in a research note issued to investors on Monday, Marketbeat Ratings reports. The firm issued a sell rating and a $23.00 price target on the pipeline company’s stock.

  • [By Reuben Gregg Brewer]

    TC Pipelines, LP (NYSE:TCP) did something that no limited partnership wants to do in May of this year: It reduced its distribution. The 35% distribution cut was clearly material for unitholders, and was compounded by a nearly 30% drop in TC Pipeline’s unit price. Although the units have gained some ground back, they remain off roughly 40% for the year. Value-conscious investors might wonder, however, if TC Pipelines, with its still generous 7.9% yield, is a buy at this point?

  • [By Money Morning Staff Reports]

    TC Pipelines LP (NYSE: TCP) is a master limited partnership (MLP) partly owned by TransCanada Corp. (NYSE: TRP), best known as the designer of the Keystone XL Pipeline. The partnership manages and owns natural gas pipelines across the Midwest and Northwestern part of the United States. The firm transports roughly 9.4 billion cubic feet of natural gas every single day.

Top 10 Value Stocks To Buy For 2019: Alexion Pharmaceuticals, Inc.(ALXN)

Advisors’ Opinion:

  • [By Chris Lange]

    When Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) released its first-quarter financial results before the markets opened on Thursday, it said that it had $1.68 in earnings per share (EPS) on $930.9 million in revenue. The consensus estimates from Thomson Reuters had called for $1.50 in EPS on revenue of $922.99 million. In the same period of last year, the pharmaceutical giant posted EPS of $1.38 and $870 million in revenue.

  • [By Chris Lange]

    Alexion Pharmaceuticals Inc.’s (NASDAQ: ALXN) short interest rose to 3.92 million shares from the previous 3.60 million. Shares were trading at $118.21, in a 52-week range of $102.10 to $147.29.

  • [By ]

    Alexion Pharmaceuticals Inc. (ALXN) is a U.S. pharma stock best known for its development of rare blood disorder drug Soliris. So far this drug has proved extremely successful. And now, the company is looking to expand into further treatment opportunities. The company is on the verge of snapping up Sweden’s Wilson Therapeutics for $855 million, further boosting (and diversifying) its rare disease lineup.

  • [By Chris Lange]

    Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) is breaking out from a bullish continuation pattern after completing a 2-year+ consolidation bottom. Upside is seen to the $200 area. Celgene Corp. (NASDAQ: CELG), Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), and Incyte Corp. (NASDAQ: INCY) have weaker technical patterns and may have further downside risks. BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is forming a potential bearish top – a move below $77.98 would open $71 to the $60 area.

  • [By Chris Lange]

    Alexion Pharmaceuticals Inc.’s (NASDAQ: ALXN) short interest rose to 4.46 million shares from the previous 3.93 million. Shares were trading at $120.14, in a 52-week range of $102.10 to $149.34.

  • [By Shane Hupp]

    Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) gapped up before the market opened on Tuesday after Stifel Nicolaus raised their price target on the stock from $130.00 to $136.00. The stock had previously closed at $127.35, but opened at $128.69. Stifel Nicolaus currently has a hold rating on the stock. Alexion Pharmaceuticals shares last traded at $128.94, with a volume of 50491 shares.

Top 10 Value Stocks To Buy For 2019: AZZ Inc.(AZZ)

Advisors’ Opinion:

  • [By Joseph Griffin]

    BlackRock Inc. boosted its holdings in AZZ Inc (NYSE:AZZ) by 7.4% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 3,534,695 shares of the industrial products company’s stock after buying an additional 242,714 shares during the period. BlackRock Inc. owned 13.58% of AZZ worth $153,583,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    AZZ (NYSE:AZZ) announced its quarterly earnings data on Tuesday. The industrial products company reported $0.60 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.47 by $0.13, MarketWatch Earnings reports. The company had revenue of $262.24 million for the quarter, compared to analysts’ expectations of $228.87 million. AZZ had a net margin of 5.50% and a return on equity of 4.99%. The business’s revenue was up 27.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.46 EPS. AZZ updated its FY19 guidance to $1.75-2.25 EPS.

  • [By Joseph Griffin]

    TRADEMARK VIOLATION WARNING: “AZZ Incorporated (AZZ) Receives Average Rating of “Hold” from Brokerages” was reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this report on another site, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this report can be viewed at www.tickerreport.com/banking-finance/3371765/azz-incorporated-azz-receives-average-rating-of-hold-from-brokerages.html.

  • [By Max Byerly]

    AZZ Inc (NYSE:AZZ) shot up 11.2% during trading on Tuesday after the company announced better than expected quarterly earnings. The stock traded as high as $51.50 and last traded at $48.50. 918,200 shares changed hands during mid-day trading, an increase of 455% from the average session volume of 165,531 shares. The stock had previously closed at $43.60.

  • [By Joseph Griffin]

    Victory Capital Management Inc. boosted its stake in shares of AZZ Inc (NYSE:AZZ) by 0.2% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 729,371 shares of the industrial products company’s stock after buying an additional 1,584 shares during the period. Victory Capital Management Inc.’s holdings in AZZ were worth $31,691,000 as of its most recent SEC filing.

  • [By Shane Hupp]

    AZZ Inc (NYSE:AZZ) declared a quarterly dividend on Friday, October 5th, Zacks reports. Shareholders of record on Tuesday, October 16th will be paid a dividend of 0.17 per share by the industrial products company on Tuesday, October 30th. This represents a $0.68 annualized dividend and a yield of 1.49%. The ex-dividend date of this dividend is Monday, October 15th.

Top 5 Undervalued Stocks To Own Right Now

Fiat Chrysler (NYSE:FCAU) is well positioned both geographically and in product terms to reap the benefits of its position, as we go into 2017. CEO Sergio Marchionne has astutely managed the strategic and brand issues involved. The company is better placed than its traditional rivals Ford (NYSE:F) and General Motors (NYSE:GM) and the stock market has undervalued its strong position. Recent announcements detailed below only serve to reinforce this strong outlook.

Europe

My article in November covered in some detail the successful increases in market share the company continues to enjoy in both Europe and North America, and the potential of the Alfa Romeo brand.

The growth in Europe has been stunning. Figures released recently show that in the first 11 months of the year, the company sold 918,600 vehicles. This was an increase of 14.2% year-on-year. This compares to an industry growth of 6.9%. The growth has been consistent across all the major European countries.

Top 5 Undervalued Stocks To Own Right Now: iShares MSCI All Peru Capped ETF (EPU)

Advisors’ Opinion:

  • [By Max Byerly]

    iShares MSCI All Peru Capped Index Fund (BMV:EPU) declared a semiannual dividend on Wednesday, June 20th, Wall Street Journal reports. Shareholders of record on Wednesday, June 20th will be given a dividend of 0.3845 per share on Monday, June 25th. This represents a yield of 1.91%. The ex-dividend date of this dividend is Tuesday, June 19th.

Top 5 Undervalued Stocks To Own Right Now: Comp En De Mn Cemig ADS(CIG)

Advisors’ Opinion:

  • [By Ethan Ryder]

    These are some of the media stories that may have impacted Accern Sentiment Analysis’s analysis:

    Get VBI Vaccines alerts:

    50 days simple moving average (SMA50) Evaluation: VBI Vaccines Inc. (NASDAQ:VBIV), Cigna Corporation (NYSE:CI … (stocksnewspoint.com) Year-to-date (YTD) under Review Companhia Energetica de Minas Gerais SA (NYSE:CIG), VBI Vaccines Inc … (stocksnewspoint.com) Investors Focused Healthcare Stock: VBI Vaccines Inc. (VBIV) (nasdaqplace.com) Have an eye on: Companhia de Saneamento Basico do Estado de Sao Paulo SABESP (NYSE:SBS), VBI Vaccines … (journalfinance.net) Should You Have this stock in Your Portfolio? VBI Vaccines Inc. (VBIV) (connectinginvestor.com)

    VBIV has been the subject of several research analyst reports. Zacks Investment Research lowered shares of VBI Vaccines from a “hold” rating to a “sell” rating in a research report on Friday, March 2nd. Noble Financial reaffirmed a “buy” rating on shares of VBI Vaccines in a research report on Friday, March 23rd. BMO Capital Markets increased their price objective on shares of VBI Vaccines from $11.00 to $13.00 and gave the company an “outperform” rating in a research report on Thursday, May 10th. Finally, ValuEngine raised shares of VBI Vaccines from a “sell” rating to a “hold” rating in a research report on Wednesday, May 2nd. Two research analysts have rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $9.42.

  • [By Logan Wallace]

    CEMIG (NYSE:CIG) has been assigned a consensus recommendation of “Hold” from the six analysts that are currently covering the company, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12-month price target among brokerages that have covered the stock in the last year is $2.80.

  • [By Stephan Byrd]

    CEMIG (NYSE:CIG) was the recipient of a significant growth in short interest during the month of June. As of June 15th, there was short interest totalling 10,718,816 shares, a growth of 174.6% from the May 31st total of 3,903,277 shares. Based on an average daily volume of 6,056,542 shares, the short-interest ratio is presently 1.8 days.

Top 5 Undervalued Stocks To Own Right Now: China Advanced Construction Materials Group, Inc.(CADC)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 155.56 percent to close at $5.75 on Thursday.
    Inspire Medical Systems, Inc. (NYSE: INSP) shares gained 56.12 percent to close at $24.98. Inspire Medical went public Thursday on the New York Stock Exchange. The company issued 6.75 million shares priced at $16 each.
    Presbia PLC (NASDAQ: LENS) shares rose 53.02 percent to close at $3.55.
    Integrated Media Technology Limited (NASDAQ: IMTE) shares rose 46.29 percent to close at $32.11. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.
    Technical Communications Corporation (NASDAQ: TCCO) climbed 27.78 percent to close at $5.75.
    STAAR Surgical Company (NASDAQ: STAA) shares gained 26.27 percent to close at $21.15 after reporting upbeat Q1 results.
    Sharing Economy International Inc. (NASDAQ: SEII) shares jumped 22.16 percent to close at $4.30 on Thursday after gaining 9.32 percent on Wednesday.
    China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) rose 20.45 percent to close at $2.65 on Thursday.
    YRC Worldwide Inc. (NASDAQ: YRCW) surged 18.36 percent to close at $9.99 following upbeat quarterly earnings.
    MYR Group Inc. (NASDAQ: MYRG) jumped 17.68 percent to close at $35.74 after the company posted strong Q1 earnings.
    Xspand Products Lab Inc (NASDAQ: XSPL) jumped 17.4 percent to close at $5.87. Xspand Products priced its IPO at $5 per share.
    Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose 17.32 percent to close at $14.90. Coherus BioSciences reported resubmission of BLA for CHS-1701.
    Rudolph Technologies, Inc. (NASDAQ: RTEC) shares gained 17.17 percent to close at $31.05 following upbeat quarterly earnings.
    The Meet Group, Inc. (NASDAQ: MEET) gained 16.02 percent to close at $2.68 following Q1 earnings.
    Ca
  • [By Lisa Levin] Gainers
    Axovant Sciences Ltd. (NASDAQ: AXON) shares rose 23.7 percent to $1.49. Axovant announced strengthening of management team and completion of organization restructuring which "enhanced capabilities in research and business development" and reduced internal headcount by 43 percent.
    Mammoth Energy Services, Inc. (NASDAQ: TUSK) shares jumped 19.8 percent to $37.3148. Mammoth Energy’s subsidiary Cobra signed a new $900 million contract to finish the restoration of critical electrical services and support the initial phase of reconstruction of the electrical utility system in Puerto Rico.
    Acorn International, Inc. (NYSE: ATV) shares gained 19 percent to $34.0201. Acorn shares rose Friday after the company declared a special one-time cash dividend of $14.97 per ADS.
    DHI Group, Inc. (NYSE: DHX) shares surged 19 percent to $2.20.
    My Size, Inc. (NASDAQ: MYSZ) climbed 16.8 percent to $1.18 after the company received a Notice of Allowance from the USPTO for measurement technology patent.
    Global Eagle Entertainment Inc. (NASDAQ: ENT) gained 16.6 percent to $2.32.
    Leju Holdings Limited (NYSE: LEJU) gained 16.5 percent to $1.34 following Q1 beat.
    Evolus, Inc. (NASDAQ: EOLS) shares surged 16.5 percent to $26.1499. Evolus named Lauren Silvernail as Chief Financial Officer and Executive Vice President, Corporate Development.
    Jupai Holdings Limited (NYSE: JP) shares gained 15 percent to $26.29 after reporting Q1 results.
    Momo Inc. (NASDAQ: MOMO) shares gained 15 percent to $44.7702 after the company reported better-than-expected results for its first quarter and issued strong sales forecast for the second quarter.
    Windstream Holdings, Inc. (NASDAQ: WIN) rose 15 percent to $7.075.
    China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) gained 14.4 percent to $2.746.
    American Woodmark Corporation (NASDAQ: AMWD) climbed 14.2 percent to $101.10 after the company reported upbeat Q4 results.
    Savara Inc. (NAS

Top 5 Undervalued Stocks To Own Right Now: Alexion Pharmaceuticals, Inc.(ALXN)

Advisors’ Opinion:

  • [By Chris Lange]

    Alexion Pharmaceuticals Inc.s (NASDAQ: ALXN) short interest dropped to 3.99 million shares from the previous level of 4.37 million. Shares were trading at $122.43, in a 52-week range of $102.10 to $149.34.

  • [By Joseph Griffin]

    Federated Investors Inc. PA reduced its stake in shares of Alexion Pharmaceuticals (NASDAQ:ALXN) by 86.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,571 shares of the biopharmaceutical company’s stock after selling 167,443 shares during the quarter. Federated Investors Inc. PA’s holdings in Alexion Pharmaceuticals were worth $2,960,000 at the end of the most recent quarter.

  • [By Chris Lange]

    Alexion Pharmaceuticals Inc.s (NASDAQ: ALXN) short interest rose to 4.24 million shares from the previous level of 3.99 million. Shares were trading at $131.12, in a 52-week range of $102.10 to $149.34.

Top 5 Undervalued Stocks To Own Right Now: SodaStream International Ltd.(SODA)

Advisors’ Opinion:

  • [By Jeremy Bowman]

    I’m talking aboutSodaStream International(NASDAQ:SODA), of course, the Israeli do-it-yourself sparkling water specialist. Shares of SodaStream sold off following the earnings report on Wednesday even though the company once again beat earnings and revenue estimates. Below were the key figures from the first-quarter report.

  • [By Jeremy Bowman, Rich Smith, and John Bromels]

    Buffett fans probably already have a sense of what kind of stocks the Oracle of Omaha like, but you may not have thought of these three. Keep reading to see why our contributors recommendExxonMobil(NYSE:XOM),Comcast(NASDAQ:CMCSA), andSodaStream International(NASDAQ:SODA).

  • [By Stephan Byrd]

    SodaStream (NASDAQ:SODA)‘s stock had its “hold” rating reiterated by stock analysts at Jefferies Group in a research note issued to investors on Wednesday. They currently have a $82.00 price target on the stock. Jefferies Group’s target price suggests a potential downside of 5.87% from the stock’s current price. Jefferies Group also issued estimates for SodaStream’s Q2 2018 earnings at $0.74 EPS, FY2018 earnings at $3.55 EPS, Q1 2019 earnings at $0.88 EPS, Q2 2019 earnings at $0.79 EPS and Q1 2020 earnings at $0.89 EPS.

Top Blue Chip Stocks To Buy Right Now

p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; text-align: justify; font: 13.0px Verdana; -webkit-text-stroke: #000000} span.s1 {font-kerning: none}

Dow 19,000 has a nice ring to it. And the iconic blue chip stock gauge is edging ever closer to that milestone.

After Mondays record-breaking day, when the Dow Jones industrial average, large-company Standard & Poors 500 stock index, tech-dominated Nasdaq composite and the small-cap Russell 2000 all closed at record levels at the same time for the first time since Dec. 31, 1999, the Dow is on the verge of making more headlines and getting a big shout outon the evening news.

.oembed-asset-link { border-bottom: 1px solid #e1e1e1; } .oembed-link-anchor { display: block; clear: both; } .oembed-link-thumbnail{ float: left; padding: 14px; } .oembed-link-thumbnail img { max-width: 78px; max-height: 60px; display: block; } p.oembed-link-title { font-size: 75%; color: #009BFF; margin: 0 14px; padding-top: 12px; font-weight:normal; text-align: left; line-height: 120%; } p.oembed-link-desc { font-size: 100%; color: #666; font-weight: normal; margin: 0 14px 14px 14px; font-family: ‘Futura Today Light’; text-align: left; line-height: 120%; }

USA TODAY

Top Blue Chip Stocks To Buy Right Now: Canadian Solar Inc.(CSIQ)

Advisors’ Opinion:

  • [By Lisa Levin]

    Canadian Solar Inc. (NASDAQ: CSIQ) is projected to report quarterly earnings at $0.47 per share on revenue of $1.34 billion.

    Magal Security Systems Ltd. (NASDAQ: MAGS) is expected to report earnings for its first quarter.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Verastem, Inc. (NASDAQ: VSTM) fell 9.7 percent to $4.73 in pre-market trading after announcing a $35 million common stock offering.
    Evolus, Inc. (NASDAQ: EOLS) shares fell 8 percent to $13.48 in pre-market trading ahead of regulatory update at 8:30 a.m. ET.
    XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) fell 6.5 percent to $2.01 in pre-market trading after climbing 10.50 percent on Tuesday.
    Purple Innovation, Inc. (NASDAQ: PRPL) shares fell 5.8 percent to $9.36 in pre-market trading after reporting Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) fell 5.7 percent to $5.15 in pre-market trading after declining 5.04 percent on Tuesday.
    RYB Education, Inc. (NYSE: RYB) shares fell 5 percent to $16.39 in pre-market trading following Q1 results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares fell 4.4 percent to $4.30 in pre-market trading after rising 40.62 percent on Tuesday.
    Arbor Realty Trust, Inc. (NYSE: ABR) fell 4.4 percent to $8.92 in pre-market trading after announcing a 5.5 million share common stock offering.
    Daxor Corporation (NYSE: DXR) fell 4.1 percent to $7.32 in pre-market trading.
    Ormat Technologies, Inc. (NYSE: ORA) shares fell 3.8 percent to $51.03 in pre-market trading after the company announced plans to restate its Q2, Q3, Q4 and FY 2017 financial statements.
    Canadian Solar Inc. (NASDAQ: CSIQ) fell 3.5 percent to $16.20 in pre-market trading after reporting Q1 results.
    CELYAD SA/ADR (NASDAQ: CYAD) shares fell 3.3 percent to $29.70 in pre-market trading after the company reported launch of 1.8 million share offering

  • [By Garrett Baldwin]

    Yesterday, North Korean officials threatened to pull out of next month’s summit with President Donald Trump over demands tied to its nuclear weapons program. The announcement comes when tensions are already high over increasing inflation fears, Japan’s economic contraction, and uncertainty around trade between the U.S. and China. Markets are likely to continue to react with uncertainty as the global political climate continues to grow increasingly volatile. WTI crude oil remained near $71.00 despite concerns as markets look to the Energy Information Administration on the state of U.S. inventory levels. Oil prices have been under pressure after the U.S. announced it would pull out of the Iran Nuclear Deal. The American Petroleum Institute projected Tuesday that U.S. stocks increased by 4.9 million barrels to 435 million barrels. The EIA will release its official report later this morning.
    Three Stocks to Watch Today: M, SBUX, AMZN
    Macy’s Inc. (NYSE: M) will lead another busy day of earnings reports. The retail company’s stock surged more than 12% this morning after a huge earnings report that crushed Wall Street expectations. The firm reported EPS of $0.48, topping expectations of $0.37 by 11 cents. The company also beat revenue expectations by roughly $100 million and experienced a huge jump in same-store sales. It doesn’t look like the U.S-China trade dispute will impact Starbucks Corporation (Nasdaq: SBUX). The coffee giant announced plans to build 3,000 new stores in China in the coming years. The company aims to double its store-front presence by the end of 2022 and hopes to double its profits and triple its revenue in the nation in the process. Amazon.com (Nasdaq: AMZN) is back in the news as it continues its slash-and-burn campaign against rival grocery store operators. This morning, the company announced it was slashing Whole Foods prices for its Prime members. The new price list includes 10% discounts on hundreds of items. The perks are rolling ou

  • [By Travis Hoium]

    Canadian Solar (NASDAQ:CSIQ) is one of the biggest solar manufacturers in the world, producing about seven out of every 100 solar panels made last year. But the company doesn’t just make solar panels; it’s also become a leading developer of solar projects with a large presence in Brazil, Mexico, China, and the U.S.

Top Blue Chip Stocks To Buy Right Now: Winnebago Industries Inc.(WGO)

Advisors’ Opinion:

  • [By Stephan Byrd]

    COPYRIGHT VIOLATION NOTICE: “White Gold Corp. (WGO) Director David D’onofrio Acquires 49,000 Shares” was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this news story on another website, it was illegally stolen and reposted in violation of US & international trademark & copyright law. The correct version of this news story can be accessed at www.tickerreport.com/banking-finance/3377822/white-gold-corp-wgo-director-david-donofrio-acquires-49000-shares.html.

  • [By ]

    Cramer was bearish on Grubhub (GRUB) , Sprint (S) , LG Homes (LGIH) , Acadia Pharmaceuticals (ACAD) , Pilgrim’s Pride (PPC) , Opko Health (OPK) , Alaska Air Group (ALK) and Winnebago Industries (WGO) .

  • [By ]

    LCI Industries (LCII) fell 5% on the day. Patrick Industries Inc. (PATK) dropped 4.24%. Thor Industries Inc. (THO) tanked 9.83%. Winnebago Industries Inc. (WGO) fell 8.85%. 

  • [By Stephan Byrd]

    WavesGo (CURRENCY:WGO) traded down 23.9% against the U.S. dollar during the one day period ending at 9:00 AM E.T. on April 21st. WavesGo has a total market capitalization of $305,137.00 and $39.00 worth of WavesGo was traded on exchanges in the last 24 hours. One WavesGo token can currently be purchased for about $0.0328 or 0.00000376 BTC on major cryptocurrency exchanges including Waves Decentralized Exchange and Tidex. During the last seven days, WavesGo has traded down 12.5% against the U.S. dollar.

  • [By ]

    Winnebago Industries (WGO) : “This group trades badly. All we hear about is an inventory glut. We need someone to tell us otherwise.”

    Cramer and the AAP team say today’s weakness is the opportunity they have been patiently waiting for. Their target? Nordstrom (JWN) . Find out what they’re telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

Top Blue Chip Stocks To Buy Right Now: Alexion Pharmaceuticals, Inc.(ALXN)

Advisors’ Opinion:

  • [By Brian Feroldi]

    In response to the company reporting expectation-topping first-quarter results and sharing upbeat pipeline news, shares of Alexion Pharmaceuticals (NASDAQ:ALXN) jumped 12% as of 3:15 p.m. EDT on Thursday.

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) shares gained 86.76 percent to close at $11.00 on Thursday.
    Comstock Resources, Inc. (NYSE: CRK) shares climbed 47.06 percent to close at $7.00 after the company disclosed a deal with Arkoma Drilling L.P. and Williston Drilling, L.P. to buy oil & gas properties in North Dakota. Comstock announced withdrawal of tender offers for outstanding secured notes.
    Ceridian HCM Holding Inc. (NASDAQ: CDAY) gained 41.86 percent to close at $31.21.
    MarineMax, Inc. (NYSE: HZO) shares rose 26.5 percent to close at $22.20 as the company posted upbeat Q2 results and raised its FY18 outlook.
    Concord Medical Services Holdings Limited (NYSE: CCM) jumped 24.92 percent to close at $4.06.
    Mattersight Corporation (NASDAQ: MATR) shares climbed 23.26 percent to close at $2.65 after the company agreed to be purchased by NICE Ltd.
    Chipotle Mexican Grill, Inc. (NYSE: CMG) rose 24.44 percent to close at $422.50 as the company reported stronger-than-expected results for its first quarter on Wednesday.
    Ultra Clean Holdings, Inc. (NASDAQ: UCTT) gained 17.75 percent to close at $18.64 following upbeat Q1 earnings.
    PCM, Inc. (NASDAQ: PCMI) rose 16.59 percent to close at $12.30 following Q1 results.
    Zymeworks Inc. (NASDAQ: ZYME) rose 16.06 percent to close at $15.25.
    Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) shares climbed 14.5 percent to close at $121.42 as the company posted reported Q1 beat And raised FY18 outlook.
    Advanced Micro Devices, Inc. (NASDAQ: AMD) shares gained 13.7 percent to close at $11.04 as the company reported upbeat results for its first quarter.
    Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 13.21 percent to close at $3.00 after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression.
    O'Reilly Automotive, Inc. (NASDAQ: ORLY) jumped 13.06 percent to close at $257.40 following upbeat Q1 profit.
    BioTelemetry,
  • [By ]

    Alexion Pharmaceuticals Inc. (ALXN) is a U.S. pharma stock best known for its development of rare blood disorder drug Soliris. So far this drug has proved extremely successful. And now, the company is looking to expand into further treatment opportunities. The company is on the verge of snapping up Sweden’s Wilson Therapeutics for $855 million, further boosting (and diversifying) its rare disease lineup.

  • [By Chris Lange]

    Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) is scheduled to reveal its first-quarter results Thursday morning. The consensus forecast calls for EPS of $1.50 and $922.99 million in revenue. Shares were trading at $107.78 on Fridays close. The consensus price target is $158.60, while the 52-week range is $96.18 to $149.34.

  • [By Chris Lange]

    Alexion Pharmaceuticals Inc.s (NASDAQ: ALXN) short interest rose to 4.64 million shares from the previous level of 4.57 million. Shares were trading at $116.55, in a 52-week range of $96.18 to $149.34.

  • [By Joseph Griffin]

    ING Groep NV lowered its holdings in Alexion Pharmaceuticals (NASDAQ:ALXN) by 63.7% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 19,333 shares of the biopharmaceutical company’s stock after selling 33,994 shares during the period. ING Groep NV’s holdings in Alexion Pharmaceuticals were worth $2,155,000 at the end of the most recent quarter.

Top Blue Chip Stocks To Buy Right Now: CarMax Inc(KMX)

Advisors’ Opinion:

  • [By Andy Pai]

    CarMax, Inc (NYSE: KMX) is the second most undervalued stock in the portfolio. The company's blended upside of 17.8 percent is very intriguing.

  • [By Trey Thoelcke]

    CarMax Inc. (NYSE: KMX) is set to release its most recent quarterly results first thing on Wednesday. The consensus forecast calls for $0.88 in EPS and $4.21 billion in revenue for the fiscal fourth quarter. Shares traded on Thursdays close at $61.94. The consensus price target is $77.71, and the 52-week range is $54.29 to $77.64.

  • [By ]

    Winners will collect specialized data, and their customers will understand why they are providing data. Among the companies that are already doing this is CarMax (NYSE: KMX).

  • [By Demitrios Kalogeropoulos]

    CarMax (NYSE:KMX) recently posted quarterly earnings results that were marked by a slowdown in sales growth. The used-car retailer endured a painful drop in customer traffic, which led sales to inch higher by less than 1% despite an aggressive expansion in its store base.

Top 5 Heal Care Stocks To Invest In 2018

&l;p&g;When it comes to retirement, it can be overwhelming to try and determine which issues to tackle first &a;ndash; or even figure out what issues exist that need tackling. We all like to imagine we&a;rsquo;ve got our ducks in a row by the time we hit our golden years, but time and time again I&a;rsquo;ve seen retirees get bogged down in details and end up more exasperated figuring out how to retire than they ever were at the office.

I&a;rsquo;ve spent 31 years in the financial services industry, 15 of which solely focusing on helping retirees and pre-retirees navigate the financial side of retirement. Unsurprisingly, I&a;rsquo;ve learned over time that almost all of us are on the same wavelength when it comes to our fears and concerns upon entering this phase of our lives. By working hand-in-hand with my clients in developing a retirement strategy to meet their specific goals, I&a;rsquo;ve learned that planning boils down to three core questions.

The first question on everyone&a;rsquo;s mind is a simple one: Where will my income come from?

Top 5 Heal Care Stocks To Invest In 2018: RBC Bearings Incorporated(ROLL)

Advisors’ Opinion:

  • [By Shane Hupp]

    Shares of RBC Bearings Incorporated (NASDAQ:ROLL) have earned an average rating of “Buy” from the six brokerages that are covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 1 year target price among brokerages that have covered the stock in the last year is $140.67.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on RBC Bearings (ROLL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Heal Care Stocks To Invest In 2018: Nuance Communications Inc.(NUAN)

Advisors’ Opinion:

  • [By Paul Ausick]

    Nuance Communications Inc. (NASDAQ: NUAN) dropped about 20% Thursday to post a new 52-week low of $12.19. Shares closed at $15.28 on Wednesday and the stock’s 52-week high is $19.49. Volume of around 19 million shares was about nine times the daily average. The company reported indifferent results Wednesday night but cut its outlook for revenue growth.

  • [By Ethan Ryder]

    Nuance Communications (NASDAQ:NUAN) had its price objective cut by Stifel Nicolaus from $18.00 to $15.00 in a report issued on Thursday. The brokerage currently has a “hold” rating on the software maker’s stock. Stifel Nicolaus’ target price indicates a potential upside of 15.03% from the company’s current price.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    MDC Partners Inc. (NASDAQ: MDCA) fell 23.4 percent to $5.25 in pre-market trading after a first-quarter earnings miss.
    Hudson Technologies Inc. (NASDAQ: HDSN) shares fell 15.1 percent to $3.48 in pre-market trading after the company reported downbeat Q1 earnings.
    Nuance Communications, Inc. (NASDAQ: NUAN) fell 14 percent to $13.15 in pre-market trading after the company posted downbeat Q2 earnings and lowered FY18 organic growth guidance.
    Myomo, Inc. (NYSE: MYO) fell 13.2 percent to $3.10 in pre-market trading after reporting downbeat quarterly results.
    Rowan Companies plc (NYSE: RDC) shares fell 10.7 percent to $14.13 in pre-market trading after climbing 8.50 percent on Wednesday.
    BT Group plc (NYSE: BT) fell 9 percent to $14.80 in pre-market trading after the company reported Q4 results and announced plans to cut 13,000 jobs over the next three years.
    Exelixis, Inc. (NASDAQ: EXEL) fell 8.3 percent to $19.90 in pre-market trading after the company disclosed that IMblaze370 Phase 3 pivotal trial of atezolizumab and cobimetinib in patients with heavily pretreated locally advanced or metastatic colorectal cancer did not meet primary endpoint.
    Infinera Corporation (NASDAQ: INFN) fell 8.2 percent to $10.80 in pre-market trading after reporting Q1 results.
    Synaptics, Incorporated (NASDAQ: SYNA) shares fell 7.4 percent to $43.00 in pre-market trading. Synaptics reported better-than-expected earnings for its third quarter, while sales missed estimates.
    Randgold Resources Limited (NASDAQ: GOLD) shares fell 7.4 percent to $76.23 in pre-market trading after reporting Q1 earnings.
    Integra LifeSciences Holdings Corporation (NASDAQ: IART) shares fell 7 percent to $59.36 in pre-market trading. Integra LifeSciences priced its 5.25 million share public offering of common stock at $58.50 per share.
    Array BioPharma Inc. (NASDAQ: ARRY) shares fell 6.9 percent to $12.75 in pre-m

Top 5 Heal Care Stocks To Invest In 2018: NeoGenomics, Inc.(NEO)

Advisors’ Opinion:

  • [By Shane Hupp]

    NeoGenomics (NASDAQ:NEO) has been given a consensus recommendation of “Buy” by the twelve ratings firms that are currently covering the firm, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation, seven have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $17.29.

  • [By Shane Hupp]

    NEO (CURRENCY:NEO) traded up 6.9% against the US dollar during the 24 hour period ending at 7:00 AM Eastern on April 15th. NEO has a total market cap of $4.40 billion and $88.39 million worth of NEO was traded on exchanges in the last day. One NEO coin can now be purchased for about $67.68 or 0.00809123 BTC on popular cryptocurrency exchanges including HitBTC, OKEx, Exrates and Upbit. During the last seven days, NEO has traded up 42.9% against the US dollar.

Top 5 Heal Care Stocks To Invest In 2018: Alexion Pharmaceuticals, Inc.(ALXN)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Thursday was a strong day on Wall Street, with the tech-heavy Nasdaq Composite leading most major benchmarks higher. Favorable earnings from the leader of the social media space suggested that concerns about the misuse of its user data were overblown, which helped to lift market sentiment and spur a rebound from recent weakness. A host of other companies had good news to report as well. Domino’s Pizza (NYSE:DPZ), Advanced Micro Devices (NASDAQ:AMD), and Alexion Pharmaceuticals (NASDAQ:ALXN) were among the best performers on the day. Here’s why they did so well.

  • [By Chris Lange]

    Alexion Pharmaceuticals Inc.s (NASDAQ: ALXN) short interest rose to 4.57 million shares from the previous level of 4.50 million. Shares were trading at $106.51, in a 52-week range of $96.18 to $149.34.

  • [By Chris Lange]

    Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) is breaking out from a bullish continuation pattern after completing a 2-year+ consolidation bottom. Upside is seen to the $200 area. Celgene Corp. (NASDAQ: CELG), Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), and Incyte Corp. (NASDAQ: INCY) have weaker technical patterns and may have further downside risks. BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is forming a potential bearish top – a move below $77.98 would open $71 to the $60 area.

  • [By ]

    Alexion Pharmaceuticals Inc. (ALXN) is a U.S. pharma stock best known for its development of rare blood disorder drug Soliris. So far this drug has proved extremely successful. And now, the company is looking to expand into further treatment opportunities. The company is on the verge of snapping up Sweden’s Wilson Therapeutics for $855 million, further boosting (and diversifying) its rare disease lineup.

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) shares gained 86.76 percent to close at $11.00 on Thursday.
    Comstock Resources, Inc. (NYSE: CRK) shares climbed 47.06 percent to close at $7.00 after the company disclosed a deal with Arkoma Drilling L.P. and Williston Drilling, L.P. to buy oil & gas properties in North Dakota. Comstock announced withdrawal of tender offers for outstanding secured notes.
    Ceridian HCM Holding Inc. (NASDAQ: CDAY) gained 41.86 percent to close at $31.21.
    MarineMax, Inc. (NYSE: HZO) shares rose 26.5 percent to close at $22.20 as the company posted upbeat Q2 results and raised its FY18 outlook.
    Concord Medical Services Holdings Limited (NYSE: CCM) jumped 24.92 percent to close at $4.06.
    Mattersight Corporation (NASDAQ: MATR) shares climbed 23.26 percent to close at $2.65 after the company agreed to be purchased by NICE Ltd.
    Chipotle Mexican Grill, Inc. (NYSE: CMG) rose 24.44 percent to close at $422.50 as the company reported stronger-than-expected results for its first quarter on Wednesday.
    Ultra Clean Holdings, Inc. (NASDAQ: UCTT) gained 17.75 percent to close at $18.64 following upbeat Q1 earnings.
    PCM, Inc. (NASDAQ: PCMI) rose 16.59 percent to close at $12.30 following Q1 results.
    Zymeworks Inc. (NASDAQ: ZYME) rose 16.06 percent to close at $15.25.
    Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) shares climbed 14.5 percent to close at $121.42 as the company posted reported Q1 beat And raised FY18 outlook.
    Advanced Micro Devices, Inc. (NASDAQ: AMD) shares gained 13.7 percent to close at $11.04 as the company reported upbeat results for its first quarter.
    Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 13.21 percent to close at $3.00 after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression.
    O'Reilly Automotive, Inc. (NASDAQ: ORLY) jumped 13.06 percent to close at $257.40 following upbeat Q1 profit.
    BioTelemetry,

Top 5 Heal Care Stocks To Invest In 2018: Electronics for Imaging Inc.(EFII)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Metropolitan Life Insurance Co. NY lessened its holdings in shares of Electronics For Imaging, Inc. (NASDAQ:EFII) by 53.3% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 14,882 shares of the technology company’s stock after selling 17,018 shares during the period. Metropolitan Life Insurance Co. NY’s holdings in Electronics For Imaging were worth $439,000 at the end of the most recent reporting period.